CONTEXT: There is an increased prevalence of obesity and insulin resistance in African-American compared with Caucasian females. Metabolic inflexibility (MI) is the inability to switch the use of lipids and carbohydrates in the peripheral tissue (i.e. muscle) based upon substrate availability. OBJECTIVE: We examined whether MI exists in African-American females. MAIN OUTCOME MEASURES AND DESIGN: We measured substrate use differences during eucaloric, macronutrient-manipulated diets [high fat (50% fat, 35% carbohydrate, 15% protein) vs. low fat (30% fat, 55% carbohydrate, 15% protein)] between Caucasian and African-American women. We also compared differences in substrate use in response to insulin infusion during two-step pancreatic-euglycemic clamps and epinephrine infusion during lipolysis studies. In each study, similar groups of Caucasian and African-American women were compared. RESULTS: Caucasians had significantly higher fat oxidation (FO) (P = 0.01) and lower carbohydrate oxidation (P < 0.01) during the high-fat vs. low-fat diet, whereas no significant differences were observed in African-Americans. The African-American women also failed to significantly suppress FO during the second step of the pancreatic-euglycemic clamp despite a doubling of their fasting plasma insulin and failed to increase their FO or decrease their carbohydrate oxidation in response to epinephrine infusion as much as Caucasian women did. The response of free fatty acid turnover rates to insulin and epinephrine stimulation was similar between races. CONCLUSION: The impaired substrate use observed in African-American women during these three studies demonstrates the existence of MI and may contribute to their greater prevalence of obesity and insulin resistance.
CONTEXT: There is an increased prevalence of obesity and insulin resistance in African-American compared with Caucasian females. Metabolic inflexibility (MI) is the inability to switch the use of lipids and carbohydrates in the peripheral tissue (i.e. muscle) based upon substrate availability. OBJECTIVE: We examined whether MI exists in African-American females. MAIN OUTCOME MEASURES AND DESIGN: We measured substrate use differences during eucaloric, macronutrient-manipulated diets [high fat (50% fat, 35% carbohydrate, 15% protein) vs. low fat (30% fat, 55% carbohydrate, 15% protein)] between Caucasian and African-American women. We also compared differences in substrate use in response to insulin infusion during two-step pancreatic-euglycemic clamps and epinephrine infusion during lipolysis studies. In each study, similar groups of Caucasian and African-American women were compared. RESULTS: Caucasians had significantly higher fat oxidation (FO) (P = 0.01) and lower carbohydrate oxidation (P < 0.01) during the high-fat vs. low-fat diet, whereas no significant differences were observed in African-Americans. The African-American women also failed to significantly suppress FO during the second step of the pancreatic-euglycemic clamp despite a doubling of their fasting plasma insulin and failed to increase their FO or decrease their carbohydrate oxidation in response to epinephrine infusion as much as Caucasian women did. The response of free fatty acid turnover rates to insulin and epinephrine stimulation was similar between races. CONCLUSION: The impaired substrate use observed in African-American women during these three studies demonstrates the existence of MI and may contribute to their greater prevalence of obesity and insulin resistance.
Authors: S R Smith; L de Jonge; J J Zachwieja; H Roy; T Nguyen; J C Rood; M M Windhauser; G A Bray Journal: Am J Clin Nutr Date: 2000-02 Impact factor: 7.045
Authors: O P Bachmann; D B Dahl; K Brechtel; J Machann; M Haap; T Maier; M Loviscach; M Stumvoll; C D Claussen; F Schick; H U Häring; S Jacob Journal: Diabetes Date: 2001-11 Impact factor: 9.461
Authors: Margarita S Treuth; Agneta L Sunehag; Lynn M Trautwein; Dennis M Bier; Morey W Haymond; Nancy F Butte Journal: Am J Clin Nutr Date: 2003-02 Impact factor: 7.045
Authors: Evan S Berk; Julia A Johnson; Mijeong Lee; Kuan Zhang; Carol N Boozer; F Xavier Pi-Sunyer; Susan K Fried; Jeanine B Albu Journal: Obesity (Silver Spring) Date: 2008-01 Impact factor: 5.002
Authors: Amanda E Staiano; Deirdre M Harrington; Neil M Johannsen; Robert L Newton; Mark A Sarzynski; Damon L Swift; Peter T Katzmarzyk Journal: Ethn Dis Date: 2015 Impact factor: 1.847
Authors: Sherita Hill Golden; Arleen Brown; Jane A Cauley; Marshall H Chin; Tiffany L Gary-Webb; Catherine Kim; Julie Ann Sosa; Anne E Sumner; Blair Anton Journal: J Clin Endocrinol Metab Date: 2012-06-22 Impact factor: 5.958
Authors: Rachel-Marie Cazeau; Lindsey Rauch; Hong Huang; John A Bauer; Robert P Hoffman Journal: Metab Syndr Relat Disord Date: 2016-07-15 Impact factor: 1.894
Authors: Susan K Fried; Thomas Tittelbach; Jacob Blumenthal; Urmila Sreenivasan; Linda Robey; Jamie Yi; Sumbul Khan; Courtney Hollender; Alice S Ryan; Andrew P Goldberg Journal: J Lipid Res Date: 2009-11-25 Impact factor: 5.922